SCL trades 32.2% below Wall Street's consensus target of $75.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes SCL achieves its forward estimates and maintains a stable P/E multiple of 22.4x. This scenario reflects the blended consensus of 3 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 6, 2026, Stepan Company (SCL) has a Wall Street consensus price target of $75.00, based on estimates from 3 covering analysts. With the stock currently trading at $56.75, this represents a potential upside of +32.2%. The company has a market capitalization of $1.29B.
Analyst price targets range from a low of $75.00 to a high of $75.00, representing a 0% spread in expectations. The median target of $75.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, SCL trades at a trailing P/E of 27.7x and forward P/E of 22.4x. Analysts expect EPS to grow +507.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $41.58, with bear and bull scenarios of $26.19 and $54.78 respectively. Model confidence stands at 41/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
IOSPInnospec Inc. | $2.0B | $83.10 | $115.00 | +38.4% | Hold | 17.4x | 9 |
BCPCBalchem Corporation | $5.4B | $168.80 | $175.50 | +4.0% | Buy | 32.2x | 10 |
HWKNHawkins, Inc. | $2.9B | $138.49 | $170.00 | +22.8% | Buy | 35.2x | 1 |
ASIXAdvanSix Inc. | $547M | $20.29 | $22.00 | +8.4% | Buy | 14.1x | 6 |
KWRQuaker Chemical Corporation | $2.8B | $161.16 | $176.75 | +9.7% | Buy | 23.0x | 14 |
RPMRPM International Inc. | $14.3B | $111.62 | $124.67 | +11.7% | Buy | 20.3x | 22 |
CBTCabot Corporation | $4.5B | $86.35 | $89.75 | +3.9% | Buy | 13.7x | 15 |
HUNHuntsman Corporation | $1.9B | $10.82 | $13.60 | +25.7% | Hold | — | 33 |
TROXTronox Holdings plc | $991M | $6.21 | $8.33 | +34.1% | Buy | — | 17 |
KRNTKornit Digital Ltd. | $723M | $15.61 | $18.00 | +15.3% | Buy | 87.7x | 13 |
Quick answers to the most common questions about buying SCL stock.
The consensus Wall Street price target for SCL is $75, representing 32.2% upside from the current price of $56.75. With 3 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
SCL has a consensus rating of "Buy" based on 3 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $75 implies 32.2% upside from current levels.
SCL trades at a forward P/E of 22.3866x, representing a moderate valuation. With analysts targeting $75 (32.2% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $75 for SCL, while the most conservative target is $75. The consensus of $75 represents the median expectation. Our quantitative valuation model projects a bull case target of $55 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
SCL is lightly followed, with 3 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month SCL stock forecast based on 3 Wall Street analysts shows a consensus price target of $75, with estimates ranging from $75 (bear case) to $75 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $42, with bear/bull scenarios of $26/$55.
Our quantitative valuation model calculates SCL's fair value at $42 (base case), with a bear case of $26 and bull case of $55. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 41/100.
SCL trades at a forward P/E ratio of 22.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 27.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on SCL, with a "Buy" consensus rating and $75 price target (32.2% upside). 3 of 3 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
SCL analyst price targets range from $75 to $75, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $75 consensus represents the middle ground. Our model's $26-$55 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.